Eagle Pharmaceuticals
EGRX
#10862
Rank
HK$25.79 M
Marketcap
HK$1.96
Share price
0.00%
Change (1 day)
-91.67%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$25.79 Million

As of July 2026 Eagle Pharmaceuticals has a market cap of HK$25.79 Million. This makes Eagle Pharmaceuticals the world's 10862th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$25.79 M-43.14%
2025HK$45.37 M-18%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.966 T 19,249,509.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.392 T 9,275,300.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$8.489 T 32,908,569.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.583 T 6,138,788.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$931.00 B 3,608,644.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$842.88 B 3,267,076.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$316.35 B 1,226,138.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel